Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
ACETYLCHOLINESTERASE
Myostatin
Muscle
DMSXL mice
Myotonic dystrophy
GSK3
CTG repeat contractions
Animals
Gene editing
Glutamate
Myotonic dystrophy mouse models
Long read sequencing
Glucocorticoids
Central nervous system
Acetylcholinesterase knockout mouse
Brain
CTG repeat instability
Cytoskeleton
Duchenne muscular dystrophy
Mice
CRISPR/Cas9
CONGENITAL MYATHENIC SYNDROME
RNA biology
Gene therapy
Alternative splicing
Astrocyte
Knockout
Thérapie génique
Intermediate filament
Dystrophin
Heart
Acute coronary syndrome
Cell penetrating peptide
CRISPRi
Skeletal muscle
Desmin
Dilated cardiomyopathy
Motoneuron
Centronuclear myopathy
ARN
Neuron
DM1
Expression
CMS
Fibrosis
Antisense oligonucleotide
Cell culture model
Dystrophie myotonique
Genotype phenotype correlation
PacBio
Male
KNOCKOUT MICE
AAV
Heart failure
Myelin
Humans
Oligodendrocyte
Cell model
Oligodendrocytes
Aging
Hypoxia
GABA
Trinucleotide repeat expansion
Myotonic Dystrophy
Endurance training
Myotonic dystrophy type 1
CTG repeats
Acetylcholinesterase deficiency
In vivo
Antisense oligonucleotides
Therapy
Exercice
RNA splicing
Dynamin 2
Muscular dystrophy
Transcriptomics
DMPK
Transgenic mouse
Trinucleotide Repeat Expansion
Exercise
Astrocytes
Diaphragm
Quantitative microdialysis
Brain dysfunction
Myotonic Dystrophy type 1
Gene Therapy
Glial cells
Maximal force
Glucocorticoid-receptor
Myotonic Dystrophy Type 1
Mouse model
RNA interference
Mouse models
MBNL
Autophagy
PCR
BIOLOGIE MOLECULAIRE
Transgenic mouse model
Cardiac muscle
Dystrophie Myotonique